Adler Eric's most recent trade in Lexeo Therapeutics Inc. was a trade of 2,359 Common Stock done at an average price of $4.4 . Disclosure was reported to the exchange on Feb. 19, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lexeo Therapeutics Inc. | Eric Adler | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.41 per share. | 19 Feb 2025 | 2,359 | 68,266 | - | 4.4 | 10,410 | Common Stock |
Lexeo Therapeutics Inc. | Eric Adler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 87,500 | 87,500 | - | - | Stock Option (right to buy) | |
Lexeo Therapeutics Inc. | Eric Adler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 43,750 | 70,625 | - | 0 | Common Stock | |
Lexeo Therapeutics Inc. | Eric Adler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 161,250 | 161,250 | - | - | Employee Stock Option (right to buy) | |
Lexeo Therapeutics Inc. | Adler Eric | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 26,875 | 26,875 | - | 0 | Common Stock |